Should I buy or sell Theratechnologies stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TH shares. View TH analyst ratings or view top-rated stocks .

What is Theratechnologies' stock price target for 2024?

2 analysts have issued 1 year target prices for Theratechnologies' stock. Their TH share price targets range from C$5.50 to C$5.50. On average, they predict the company's stock price to reach C$5.50 in the next twelve months. This suggests a possible upside of 150.0% from the stock's current price. View analysts price targets for TH or view top-rated stocks among Wall Street analysts .

How have TH shares performed in 2023?

Theratechnologies' stock was trading at C$1.20 at the beginning of 2023. Since then, TH stock has increased by 83.3% and is now trading at C$2.20. View the best growth stocks for 2023 here .

When is Theratechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our TH earnings forecast .

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc. (TSE:TH) posted its quarterly earnings data on Tuesday, September, 26th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $27.81 million for the quarter. Theratechnologies had a negative net margin of 36.54% and a negative trailing twelve-month return on equity of 1,116.86%.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI) , BCE (BCE) , ProMetic Life Sciences (PLI) , Teranga Gold (TGZ) , Nemaska Lithium (NMX) , Shopify (SHOP) , United Therapeutics (UTHR) and Avigilon (AVO) .

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

Theratechnologies Stock Price, News & Analysis (TSE:TH)

C$2.20

+0.05 (+2.33%)

(As of 12/1/2023 ET)

Compare

Today's Range: C$2.08
▼
C$2.24
50-Day Range: C$1.27
▼
C$2.90
52-Week Range: C$1.22
▼
C$7.96

Volume: 15,537 shs
Average Volume: 41,127 shs
Market Capitalization: C$100.80 million

P/E Ratio: N/A
Dividend Yield: 3.76%
Price Target: C$5.50

Stock Analysis Analyst Forecasts Chart Competitors Earnings Headlines Insider Trades

Theratechnologies MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 150.0% Upside
C$5.50 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
C$91,707 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Theratechnologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$5.50, Theratechnologies has a forecasted upside of 150.0% from its current price of C$2.20.
Amount of Analyst Coverage
Theratechnologies has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for TH.

1.7

Dividend Strength

Dividend Leadership
Theratechnologies is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Theratechnologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TH.

0.6

News and Social Media Coverage

Search Interest
10 people have searched for TH on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Theratechnologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$91,707.00 in company stock and sold C$0.00 in company stock.
Percentage Held by Insiders
10.47% of the stock of Theratechnologies is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 28.60% of the stock of Theratechnologies is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Theratechnologies is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Theratechnologies is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Theratechnologies, their PEG ratio cannot be calculated.

See Top Rated MarketRank™ Stocks Here

About Theratechnologies Stock (TSE:TH)

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

TH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TH Stock News Headlines

November 24, 2023 | finance.yahoo.com

Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award

November 2, 2023 | msn.com

Theratechnologies (THTX) Price Target Increased by 16.41% to 5.54

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

October 26, 2023 | msn.com

Theratechnologies prices its public offering; shares plummet

October 26, 2023 | msn.com

Why Is Theratechnologies (THTX) Stock Down 22% Today?

October 25, 2023 | msn.com

Theratechnologies proposes stock offering, private placement

October 25, 2023 | finance.yahoo.com

Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement

October 21, 2023 | theglobeandmail.com

Theratechnologies: Top 10 Undervalued Growth Stocks on TSX (TH)

December 3, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

October 14, 2023 | msn.com

Theratechnologies doses first subject in ovarian cancer trial

October 13, 2023 | finance.yahoo.com

Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study

October 13, 2023 | finance.yahoo.com

Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)

September 26, 2023 | markets.businessinsider.com

Theratechnologies: A Buy Rating Backed by Financial Stability, Clinical Progress, and Underappreciated Value Opportunities

September 26, 2023 | finance.yahoo.com

Morning News Call - Canada, September 26

September 26, 2023 | marketwatch.com

Theratechnologies Warns of Going Concern Uncertainty

September 26, 2023 | marketwatch.com

Toronto Stocks Down; Theratechnologies Falls After Going Concern Warning

September 26, 2023 | finance.yahoo.com

Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates

September 26, 2023 | sfgate.com

Theratechnologies: Fiscal Q3 Earnings Snapshot

September 26, 2023 | finance.yahoo.com

Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates

September 20, 2023 | finance.yahoo.com

Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023

September 18, 2023 | finance.yahoo.com

Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update

September 5, 2023 | finance.yahoo.com

Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights

August 25, 2023 | theglobeandmail.com

Closing Bell: Theratechnologies down on Thursday (TH)

August 21, 2023 | finance.yahoo.com

Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

August 21, 2023 | theglobeandmail.com

Theratechnologies: Top 25 Undervalued Toronto Stock Exchange Stocks (TH)

August 5, 2023 | theglobeandmail.com

Closing Bell: Theratechnologies 5.75 Pct Debs up on Tuesday (TH-DB-U)

August 2, 2023 | msn.com

Theratechnologies (THTX) Price Target Increased by 169.59% to 7.62

See More Headlines

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/26/2023
Today: 12/02/2023
Next Earnings (Estimated): 2/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:TH
CUSIP: N/A
CIK: N/A
Web: www.theratech.com
Phone: +1-514-3367800
Fax: N/A
Employees: 144
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$5.50
High Stock Price Target: C$5.50
Low Stock Price Target: C$5.50
Potential Upside/Downside: +150.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($1.68)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 54.02
P/E Growth: -8.5
Net Income: C$-29,130,000.00
Net Margins: -36.54%
Pretax Margin: N/A
Return on Equity: -1,116.86%
Return on Assets: -9.78%

Debt

Debt-to-Equity Ratio: 562.07
Current Ratio: 0.41
Quick Ratio: 0.64

Sales & Book Value

Annual Sales: C$79.73 million
Price / Sales: 1.26
Cash Flow: C$0.59 per share
Price / Cash Flow: 3.76
Book Value: C($1.72) per share
Price / Book: -1.28

Miscellaneous

Outstanding Shares: 45,820,000
Free Float: N/A
Market Cap: C$100.80 million
Optionable: Not Optionable
Beta: 1.30

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Paul Lévesque (Age 59)
President, CEO & Director
Comp: $1.81M
Mr. Philippe Dubuc M.B.A. (Age 56)
MBA, Senior VP & CFO
Comp: $620.85k
Mr. Jocelyn Lafond L.L.M. (Age 55)
LL.B., General Counsel & Corporate Secretary
Comp: $449.82k
Dr. Christian Marsolais Ph.D. (Age 60)
Senior VP & Chief Medical Officer
Comp: $644.38k
Mr. John Leasure (Age 58)
Global Commercial Officer
Comp: $709.45k
Hon. Andre Dupras M.Sc. (Age 59)
Vice President of Human Resources

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

TH Stock Analysis - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TH shares.
View TH analyst ratings or view top-rated stocks.
What is Theratechnologies' stock price target for 2024?: 2 analysts have issued 1 year target prices for Theratechnologies' stock. Their TH share price targets range from C$5.50 to C$5.50. On average, they predict the company's stock price to reach C$5.50 in the next twelve months. This suggests a possible upside of 150.0% from the stock's current price.
View analysts price targets for TH or view top-rated stocks among Wall Street analysts.
How have TH shares performed in 2023?: Theratechnologies' stock was trading at C$1.20 at the beginning of 2023. Since then, TH stock has increased by 83.3% and is now trading at C$2.20.
View the best growth stocks for 2023 here.
When is Theratechnologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our TH earnings forecast.

How were Theratechnologies' earnings last quarter?: Theratechnologies Inc. (TSE:TH) posted its quarterly earnings data on Tuesday, September, 26th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $27.81 million for the quarter. Theratechnologies had a negative net margin of 36.54% and a negative trailing twelve-month return on equity of 1,116.86%.
What other stocks do shareholders of Theratechnologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).
How do I buy shares of Theratechnologies?: Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:TH) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Theratechnologies Stock Price, News & Analysis (TSE:TH)

Theratechnologies MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About Theratechnologies Stock (TSE:TH)

TH Stock Price History

TH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

TH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™